Key Takeaways & Executive Findings
- •• Senescence-like neutrophils (CXCR4hiCD62Llo) are significantly elevated in SLE patients and correlate with disease activity and autoantibody production. • These neutrophils exhibit impaired immunosuppressive capacity, failing to suppress NK cell and CD4+ T cell proinflammatory activity. • The immunosuppressive effect is mediated by reactive oxygen species (ROS) production under physiological conditions. • Senescence-like neutrophils may serve as biomarkers for SLE activity and offer a new therapeutic target.
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a complex pathogenesis that was previously thought to involve primarily adaptive immunity. Emerging evidence underscores the role of neutrophils in shaping immune dysregulation and inducing organ damage in lupus. This study aims to investigate the dynamics of neutrophil senescence and its relationship with lupus, an area that remains poorly understood. Here, we identify a significantly elevated proportion of CXCR4hiCD62Llo senescence-like neutrophils in the peripheral blood of SLE patients compare to that in the healthy donors. Increased numbers of senescence-like neutrophils are positively correlated with SLE disease activity and autoantibody production in SLE patients. In addition, senescence-like neutrophils derived from SLE patients exhibit an impaired ability to suppress the proinflammatory activity of natural killer (NK) cells and CD4+ T cells. Further mechanistic exploration suggests that these senescence-like neutrophils might exert their immunosuppressive effects via reactive oxygen species (ROS) production under physiological conditions. Our results demonstrate that senescence-like neutrophils could serve as biomarkers for assessing the disease activity of SLE. The compromised immunosuppressive function of senescence-like neutrophils provides a new perspective on SLE pathophysiology and may pave the way for the development of novel therapies.
1. Introduction
Systemic lupus erythematosus (SLE) is a representative autoimmune disorder characterized by a complex pathogenesis and the involvement of multiple organ systems [1]. Therefore, investigating the pathogenesis of SLE is of paramount importance, as it offers a theoretical foundation for the development of targeted therapeutics.
Neutrophils are among the earliest cells in human peripheral blood that respond to microbial invasion [2]. Studies have indicated that neutrophils in patients with lupus present abnormal functions, marked by a diminished capacity for recognizing and clearing apoptotic neutrophils mediated by C1q, calreticulin, and CD91 [3]. Additionally, lupus neutrophils show an enhanced ability to form neutrophil extracellular traps (NETs), which contain substantial amounts of chromatin, double-stranded DNA, and autoantigens, such as granular proteins [4]. Moreover, neutrophils in lupus are subject to ferroptosis, and specific inhibitors of ferroptosis significantly alleviate the severity of the disease in lupus-susceptible mice [5]. These findings imply that neutrophils might play a facilitating role in the pathogenesis of lupus. However, we previously discovered that the elimination of neutrophils at an early stage in a lupus mouse model led to an exacerbation of autoimmunity, further revealing that neutrophils inhibit the IFN-γ response via reactive oxygen species (ROS) production. Both type I interferons and type II interferons (IFNs) are implicated in the pathogenesis of SLE [6]. Neutrophils may play a bidirectional regulatory role in the onset and progression of lupus.
Although neutrophils are typically considered a relatively homogeneous population, emerging evidence indicates the existence of heterogeneity. Under steady-state circumstances, neutrophil heterogeneity might arise from aging and the replenishment of freshly released neutrophils from the bone marrow. As neutrophils age, they gradually lose CD62L expression and upregulate CXCR4 level [7]. These senescence-like neutrophils constitute an overly active subset that enhances the activation of αMβ2 integrin (Mac-1) and increases the formation of NETs under inflammatory conditions. The pro-inflammatory activity of neutrophils is positively correlated with their aging in circulation. The morphology of senescence-like neutrophils is characterized by pronounced nuclear hypersegmentation [8]. However, another subset of mature human neutrophils (CD62LdimCD16bri) presenting hypersegmented nuclear morphology has been identified as a distinct circulating population of myeloid cells with the capacity to suppress human T-cell proliferation [9]. Given their overlapping and contradictory natures, the functions of senescence-like neutrophils need to be further investigated. Furthermore, the mechanism of senescence-like neutrophils in the pathogenesis of SLE has rarely been reported. This study aimed to investigate the dynamics of neutrophil senescence and its relationship with lupus.
Loading authentic research manuscript (Pages 1–5)...
Lei Han, Fengling Huang, Qingchen Zhu, Huan Wang, Tianlin Lu, Chunyuan Xiao, Jing Xu, Xiaoyan Zhang, Yichuan Xiao, Xinfang Huang (2026). Increased neutrophil senescence is associated with impaired immunosuppressive activity in systemic lupus erythematosus. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025047
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are senescence-like neutrophils?
Senescence-like neutrophils are a subset of neutrophils characterized by high CXCR4 and low CD62L expression, typically associated with aging in circulation. They exhibit hypersegmented nuclei and altered functional properties.
How do senescence-like neutrophils relate to SLE disease activity?
In SLE patients, the proportion of senescence-like neutrophils is significantly elevated and positively correlates with disease activity and autoantibody production, suggesting they may serve as biomarkers for assessing SLE activity.
What is the immunosuppressive role of senescence-like neutrophils?
Senescence-like neutrophils from healthy donors can suppress proinflammatory activity of NK cells and CD4+ T cells via reactive oxygen species (ROS) production. However, in SLE patients, this immunosuppressive ability is impaired.
What are the therapeutic implications of this study?
The findings suggest that restoring the immunosuppressive function of senescence-like neutrophils or targeting their impaired ROS production could offer novel therapeutic strategies for SLE.
What is the significance of the CXCR4hiCD62Llo phenotype?
The CXCR4hiCD62Llo phenotype defines senescence-like neutrophils in peripheral blood. This surface marker combination is used to identify this subset and is associated with aging and functional changes in neutrophils.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.